Literature DB >> 8968905

Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method.

A Hawkins1, F Davidson, P Simmonds.   

Abstract

The accuracy of different methods for the quantitation of hepatitis C virus in plasma was measured with samples from individuals infected with different genotypes and by using RNA transcripts of predetermined concentrations. Highly reproducible results were observed upon repeat testing of samples by both the original version of the Chiron branched-DNA (bDNA) assay (Quantiplex RNA assay; bDNA-1) and the currently available version (Quantiplex HCV RNA 2.0 assay; bDNA-2). A greater variability was observed in the Roche Monitor assay (correlation coefficient of 0.537, compared with 0.942 and 0.964 for the bDNA-1 and bDNA-2 assays, respectively). Significant differences in the efficiency of detection of genotypes 1, 2, and 3 were observed for the bDNA-1 and Roche Monitor assays, whereas the bDNA-2 assay and nested PCR at limiting dilution were able to quantify genotypes with equal sensitivity. By quantifying RNA transcripts of different genotypes, the sensitivities of the Roche Monitor assay for sequences of the type 2 and type 3 transcripts were estimated to be 11 and 8% of those achieved for genotype 1. When correction factors based upon these results and those from quantitation of circulating viral RNA sequences in samples from blood donors were used, the genotype-specific differences in virus load in samples from blood donors were no longer observed, consistent with previous studies with corrected values from the bDNA-1 assay. These results suggest that many of the previous studies evaluating the effect of genotype and virus load on the response to interferon using methods such as the Roche Monitor assay and other competitive PCR methods require reinterpretation. Differences in efficiency of quantitation should be taken into account in future investigations of the relationship between genotype and virus load.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8968905      PMCID: PMC229536          DOI: 10.1128/jcm.35.1.187-192.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates.

Authors:  L Q Zhang; P Simmonds; C A Ludlam; A J Brown
Journal:  AIDS       Date:  1991-06       Impact factor: 4.177

2.  Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group.

Authors:  D B Smith; J Mellor; L M Jarvis; F Davidson; J Kolberg; M Urdea; P L Yap; P Simmonds
Journal:  J Gen Virol       Date:  1995-07       Impact factor: 3.891

3.  Direct method for determining inorganic phosphate in serum with the "CentrifiChem".

Authors:  J A Daly; G Ertingshausen
Journal:  Clin Chem       Date:  1972-03       Impact factor: 8.327

4.  Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C.

Authors:  M Mizokami; E Orito; Y Gibo; K Suzuki; K Ohba; T Ohno; J Y Lau
Journal:  Liver       Date:  1996-02

5.  Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology.

Authors:  J Detmer; R Lagier; J Flynn; C Zayati; J Kolberg; M Collins; M Urdea; R Sánchez-Pescador
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

6.  Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers.

Authors:  P Simmonds; P Balfe; J F Peutherer; C A Ludlam; J O Bishop; A J Brown
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

7.  Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay.

Authors:  K K Young; R M Resnick; T W Myers
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

8.  Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants.

Authors:  S W Chan; F McOmish; E C Holmes; B Dow; J F Peutherer; E Follett; P L Yap; P Simmonds
Journal:  J Gen Virol       Date:  1992-05       Impact factor: 3.891

9.  Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities.

Authors:  F McOmish; S W Chan; B C Dow; J Gillon; W D Frame; R J Crawford; P L Yap; E A Follett; P Simmonds
Journal:  Transfusion       Date:  1993-01       Impact factor: 3.157

10.  Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users.

Authors:  P Simmonds; L Q Zhang; H G Watson; S Rebus; E D Ferguson; P Balfe; G H Leadbetter; P L Yap; J F Peutherer; C A Ludlam
Journal:  Lancet       Date:  1990-12-15       Impact factor: 79.321

View more
  29 in total

Review 1.  Molecular techniques for clinical diagnostic virology.

Authors:  S J Read; D Burnett; C G Fink
Journal:  J Clin Pathol       Date:  2000-07       Impact factor: 3.411

2.  Performance of the COBAS AMPLICOR HCV MONITOR test, version 2.0, an automated reverse transcription-PCR quantitative system for hepatitis C virus load determination.

Authors:  G Gerken; T Rothaar; M G Rumi; R Soffredini; M Trippler; M J Blunk; A Butcher; S Soviero; G Colucci
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Hepatitis C virus quantitation: optimization of strategies for detecting low-level viremia.

Authors:  W T Hofgärtner; J A Kant; K E Weck
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 4.  Molecular methods of measurement of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection: implications for occupational health practice.

Authors:  J H Kao; J Heptonstall; D S Chen
Journal:  Occup Environ Med       Date:  1999-11       Impact factor: 4.402

Review 5.  Analytical and biological variables influencing quantitative hepatitis C virus (HCV) measurement in HIV-HCV coinfection.

Authors:  C L Cooper; Curtis L Cooper; Paul MacPherson; William Cameron
Journal:  Can J Gastroenterol       Date:  2006-01       Impact factor: 3.522

6.  Clinical relevance of hepatitis C virus genotypes.

Authors:  P Simmonds
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

7.  Stability of hepatitis C virus RNA in blood samples by TaqMan real-time PCR.

Authors:  Kenan Sener; Mehmet Yapar; Orhan Bedir; Cem Gül; Omer Coskun; Ayhan Kubar
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

8.  Assessment of viral loads in patients with chronic hepatitis C with AMPLICOR HCV MONITOR version 1.0, COBAS HCV MONITOR version 2.0, and QUANTIPLEX HCV RNA version 2.0 assays.

Authors:  M Martinot-Peignoux; V Le Breton; S Fritsch; G Le Guludec; N Labouret; F Keller; P Marcellin
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

9.  Hepatitis C virus (HCV) RNA level determined by second-generation branched-DNA probe assay as predictor of response to interferon treatment in patients with chronic HCV viremia.

Authors:  Norihiro Furusyo; Jun Hayashi; Kenichiro Kashiwagi; Hisashi Nakashima; Shigeki Nabeshima; Yasunori Sawayama; Naoko Kinukawa; Seizaburo Kashiwagi
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

10.  Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection.

Authors:  M Resti; C Azzari; F Mannelli; M Moriondo; E Novembre; M de Martino; A Vierucci
Journal:  BMJ       Date:  1998-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.